Abstract
Erythroid Krüppel-like Factor (EKLF/KLF1) is an erythroid-enriched transcription factor that plays a global role in all aspects of erythropoiesis, including cell cycle control and differentiation. We queried whether its mutation might play a role in red cell malignancies by genomic sequencing of the KLF1 transcription unit in cell lines, erythroid neoplasms, dysplastic disorders, and leukemia. In addition, we queried published databases from a number of varied sources. In all cases we only found changes in commonly notated SNPs. Our results suggest that if there are mutations in KLF1 associated with erythroid malignancies, they are exceedingly rare.
Original language | English (US) |
---|---|
Article number | 6587 |
Journal | Scientific reports |
Volume | 8 |
Issue number | 1 |
DOIs | |
State | Published - Dec 1 2018 |
Funding
This work was supported by PHS grants R21 CA133608 and R01 DK46865 to JJB, and by a Cooley’s Anemia Fellowship to MNG. The Myeloproliferative Disorders Research Consortium Tissue Bank Core C was supported by grant P01 CA108671. We thank Dr John Martignetti for discussion and comments on the manuscript, and Dr Tim Ley for discussion.
ASJC Scopus subject areas
- General